Related Posts
HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
April 30, 2019
Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...
Joint Letter of Support for the MEDS Act
November 5, 2019
Dear Senator Collins and Senator Smith, The undersigned organizations are...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...
HSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we applaud the bipartisan leadership of Chairman Pallone, Chairwoman Eshoo, Ranking Member Rodgers, and Ranking Member Guthrie of the House Committee on Energy & Commerce on the Food and Drug Amendments Act of 2022, which the House of Representatives recently passed with overwhelming support by a vote of 392-28. Timely access to safe and effective drugs, devices, products, and biologics for all Americans is of critical importance to GPOs, which serve as the sourcing partners to virtually all hospitals, clinics, ambulatory surgery centers, and long-term care facilities.
Click here to read the full letter.